High dose toremifene as a cisplatin modulator: Targeted plasma levels are achievable clinically

被引:0
|
作者
Gandara, DR
Lara, P
Cadman, T
Lau, D
Uhrich, M
Turrell, C
Morgan, R
Dimery, I
Edelman, M
Perez, EA
Synold, T
Doroshow, J
Muggia, F
DeGregorio, M
机构
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[2] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[3] Univ So Calif, Los Angeles, CA 90089 USA
[4] Mayo Clin, Jacksonville, FL 32224 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:148A / 148A
页数:1
相关论文
共 50 条
  • [11] THE UPPER LIMIT OF THE METHOTREXATE (MTX) CSF LEVELS ACHIEVABLE IN CHILDREN WITH BRAIN TUMORS TREATED WITH HIGH DOSE INTRAVENOUS MTX
    Cohen, Ian
    Toledano, Helen
    Ash, Shifra
    Goshen, Yaacov
    Cohen, Eytan
    Yaniv, Isaac
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 728 - 728
  • [12] Activity of high-dose toremifene plus cisplatin in platinum-treated nonsmall-cell lung cancer: a phase II California Cancer Consortium Trial
    Lara, PN
    Gandara, DR
    Longmate, J
    Gumerlock, PH
    Martin, DHML
    Edelman, J
    Gandour-Edwards, R
    Mack, PC
    Israel, V
    Raschko, J
    Frankel, P
    Perez, EA
    Lenz, HJ
    Doroshow, JH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (01) : 22 - 28
  • [13] HIGH-DOSE DESIPRAMINE, PLASMA DRUG LEVELS AND CLINICAL-RESPONSE
    AMSTERDAM, J
    BRUNSWICK, DJ
    MENDELS, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1979, 40 (03) : 141 - 143
  • [14] PLASMA AND CSF METHOTREXATE LEVELS DURING HIGH-DOSE METHOTREXATE CHEMOTHERAPY
    GILCHRIST, NL
    CALDWELL, J
    WATSON, ID
    CUNNINGHAM, D
    FORREST, GJ
    SOUKOP, M
    BRITISH JOURNAL OF CANCER, 1985, 51 (04) : 590 - 590
  • [15] Cisplatin, high dose cytosine and dexamethasone (DHAP) as a PBSC mobilisation regime in plasma cell myeloma.
    Douglas, KW
    Cook, G
    Farrell, E
    Green, R
    Alcorn, M
    Pearson, C
    Tansey, P
    Franklin, IM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 49 - 49
  • [16] Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial
    Primo N. Lara
    David R. Gandara
    Jeff Longmate
    Paul H. Gumerlock
    Derick H. Lau
    Martin J. Edelman
    Regina Gandour-Edwards
    Philip C. Mack
    Valerie Israel
    James Raschko
    Paul Frankel
    Edith A. Perez
    Heinz Lenz
    James H. Doroshow
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 22 - 28
  • [17] High resolution propagation-based lung imaging at clinically relevant X-ray dose levels
    Albers, Jonas
    Wagner, Willi L.
    Fiedler, Mascha O.
    Rothermel, Anne
    Wuennemann, Felix
    Di Lillo, Francesca
    Dreossi, Diego
    Sodini, Nicola
    Baratella, Elisa
    Confalonieri, Marco
    Arfelli, Fulvia
    Kalenka, Armin
    Lotz, Joachim
    Biederer, Juergen
    Wielpuetz, Mark O.
    Kauczor, Hans-Ulrich
    Alves, Frauke
    Tromba, Giuliana
    Dullin, Christian
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [18] High resolution propagation-based lung imaging at clinically relevant X-ray dose levels
    Jonas Albers
    Willi L. Wagner
    Mascha O. Fiedler
    Anne Rothermel
    Felix Wünnemann
    Francesca Di Lillo
    Diego Dreossi
    Nicola Sodini
    Elisa Baratella
    Marco Confalonieri
    Fulvia Arfelli
    Armin Kalenka
    Joachim Lotz
    Jürgen Biederer
    Mark O. Wielpütz
    Hans-Ulrich Kauczor
    Frauke Alves
    Giuliana Tromba
    Christian Dullin
    Scientific Reports, 13
  • [19] High-dose fibrinogen versus a clinically recommended dose of fresh frozen plasma for reversal of dilutional coagulopathy in an in vitro model of severe hemodilution
    Rosenthal, C.
    Rau, J.
    Volk, T.
    Sander, M.
    Ziemer, S.
    Von Heymann, C.
    MINERVA ANESTESIOLOGICA, 2014, 80 (08) : 894 - 903
  • [20] Factors Affecting the Upper Limit of the Methotrexate (MTX) CSF Levels Achievable in Children With Brain Tumors Treated With High-dose Intravenous MTX
    Zemer, Vered Shkalim
    Toledano, Helen
    Ash, Shifra
    Cohen, Eytan
    Yaniv, Isaac
    Cohen, Ian J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (07) : 544 - 548